# CYP1B1

## Overview
CYP1B1 is a gene that encodes the enzyme cytochrome P450 family 1 subfamily B member 1, a crucial component of the cytochrome P450 superfamily. This enzyme is categorized as a monooxygenase and is involved in the metabolism of various endogenous and exogenous compounds. It plays a significant role in the oxidative metabolism of substances such as estradiol, arachidonic acid, and vitamin A, contributing to processes like hormone synthesis and detoxification (Song2022Cytochrome). CYP1B1 is predominantly expressed in extrahepatic tissues, including the brain and ocular tissues, where it is essential for maintaining iron homeostasis and redox balance (Song2022Cytochrome). Mutations in the CYP1B1 gene are linked to several forms of glaucoma, highlighting its clinical significance in ocular health (ChavarriaSoley2008Mutations). Additionally, CYP1B1 is implicated in cancer biology due to its role in estrogen metabolism and carcinogen activation, making it a potential target for therapeutic interventions (Alsubait2020CYP1B1).

## Structure
The CYP1B1 protein is a member of the cytochrome P450 superfamily, characterized by its heme-thiolate structure. Its primary structure consists of a sequence of amino acids that form a compact, globular shape in its tertiary structure. The secondary structure of CYP1B1 includes 12 α-helices and 4 β-sheets, which are common features among cytochrome P450 enzymes (Itoh2010A). The protein's active site is closed and planar, with a volume of 550 Å³, larger than that of CYP1A2, and is involved in substrate recognition (Itoh2010A).

CYP1B1 contains specific domains and residues critical for its function. The ERR triad (E387, R390, R444) forms a conserved folding core, while Thr334 plays a role in oxygen activation (Itoh2010A). The heme moiety is covalently linked to Cys470, stabilizing the structure through interactions such as ion-pairing, π/π stacking, and hydrogen bonding (Lewis2003Molecular). The protein's active site includes hydrophobic residues and aromatic sidechains like Phe181 and Tyr437, which facilitate substrate orientation and inhibitor binding (Lewis1999Molecular). The A330F mutation in the SRS4 region affects substrate binding and turnover, highlighting the importance of this conserved region (Choudhary2008Characterization).

## Function
CYP1B1 is a member of the cytochrome P450 superfamily, primarily expressed in extrahepatic tissues such as the brain, ocular tissues, and various other organs. It plays a crucial role in the metabolism of both exogenous chemicals, like polycyclic aromatic hydrocarbons, and endogenous bioactive compounds, including estradiol, arachidonic acid, vitamin A, and melatonin (Song2022Cytochrome). In the eye, CYP1B1 is involved in maintaining ocular iron homeostasis and redox balance, particularly in the retina, where it regulates the ferroportin-hepcidin axis to manage iron levels and prevent oxidative stress (Song2022Cytochrome).

CYP1B1 also participates in the oxidative metabolism of vitamin A, converting retinol to retinal and retinoic acid, which are important for vision and immune function (Song2022Cytochrome). The enzyme's activity is linked to the regulation of iron levels in the eye, potentially through the modulation of proteins involved in iron regulation in retinal endothelial cells (Song2022Cytochrome). Its expression is regulated by the aryl hydrocarbon receptor (AhR) and is highly expressed in various cancers, where it influences the expression of BMP6 and hepcidin, key regulators of iron levels (Song2022Cytochrome).

## Clinical Significance
Mutations in the CYP1B1 gene are primarily associated with various forms of glaucoma, including primary congenital glaucoma (PCG), primary open-angle glaucoma (POAG), and juvenile open-angle glaucoma (JOAG). PCG is characterized by developmental defects in the eye's anterior chamber, leading to increased intraocular pressure and potential vision loss. It is often inherited in an autosomal recessive manner with variable penetrance (Vasiliou2008Role; ChavarriaSoley2008Mutations). CYP1B1 mutations can result in reduced enzymatic activity or abundance, contributing to the pathogenesis of PCG (ChavarriaSoley2008Mutations). Specific mutations, such as p.G61E and p.L343del, have been identified as causative factors (ChavarriaSoley2008Mutations).

CYP1B1 is also implicated in various cancers due to its role in the hydroxylation of estrogens and activation of carcinogens, which can lead to tumorigenesis. The gene is highly expressed in cancerous tissues, including those of the brain, breast, and prostate, and is considered a potential biomarker and target for anticancer drugs (Alsubait2020CYP1B1). Alterations in CYP1B1 expression can lead to the formation of DNA adducts and reactive oxygen species, contributing to DNA mutations and irregular gene expression (Alsubait2020CYP1B1).

## Interactions
CYP1B1, a member of the cytochrome P450 family, is involved in various interactions with other proteins, although specific physical interactions are not extensively detailed in the literature. The interaction between cytochrome b5 (CYB5) and CYP1B1 has been characterized as an entropy-driven complex, suggesting involvement of hydrophobic interactions and desolvation of hydrophobic regions. Despite this interaction, CYB5 does not affect the activity of CYP1B1, and the reason for this non-functional complex formation remains unclear (Yablokov2017Thermodynamics).

CYP1B1 is also implicated in the metabolism of estrogens, where it converts 17β-oestradiol into catechol estrogens, which can be further oxidized to reactive ortho-quinones. These quinones can bind covalently to biological macromolecules, suggesting potential interactions with cellular components (Roos2005Cytochrome). The regulation of CYP1B1 by estrogens via estrogen receptor-α indicates a transcriptional interaction, although specific physical interactions with nucleic acids are not detailed (Roos2005Cytochrome).

While CYP1B1's role in the metabolism of carcinogens and its expression in various cancers is well-documented, specific details on its physical interactions with other proteins or nucleic acids remain limited (Murray2001Regulation; Roos2005Cytochrome).


## References


[1. (Itoh2010A) Toshimasa Itoh, Hitomi Takemura, Kayoko Shimoi, and Keiko Yamamoto. A 3d model of cyp1b1 explains the dominant 4-hydroxylation of estradiol. Journal of Chemical Information and Modeling, 50(6):1173–1178, May 2010. URL: http://dx.doi.org/10.1021/ci1000554, doi:10.1021/ci1000554. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/ci1000554)

[2. (Choudhary2008Characterization) Dharamainder Choudhary, Ingela Jansson, Mansoor Sarfarazi, and John B. Schenkman. Characterization of the biochemical and structural phenotypes of four cyp1b1 mutations observed in individuals with primary congenital glaucoma. Pharmacogenetics and Genomics, 18(8):665–676, August 2008. URL: http://dx.doi.org/10.1097/fpc.0b013e3282ff5a36, doi:10.1097/fpc.0b013e3282ff5a36. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/fpc.0b013e3282ff5a36)

[3. (Lewis2003Molecular) David F.V. Lewis, Elizabeth M.J. Gillam, Steven A. Everett, and Tsutomu Shimada. Molecular modelling of human cyp1b1 substrate interactions and investigation of allelic variant effects on metabolism. Chemico-Biological Interactions, 145(3):281–295, June 2003. URL: http://dx.doi.org/10.1016/s0009-2797(03)00021-8, doi:10.1016/s0009-2797(03)00021-8. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0009-2797(03)00021-8)

[4. (Murray2001Regulation) Graeme I Murray, William T Melvin, William F Greenlee, and M Danny Burke. Regulation, function, and tissue-specific expression of cytochrome p450 cyp1b1. Annual Review of Pharmacology and Toxicology, 41(1):297–316, April 2001. URL: http://dx.doi.org/10.1146/annurev.pharmtox.41.1.297, doi:10.1146/annurev.pharmtox.41.1.297. This article has 248 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.pharmtox.41.1.297)

[5. (Alsubait2020CYP1B1) Arwa Alsubait, Wadha Aldossary, Mamoon Rashid, Amani Algamdi, and Bahauddeen M. Alrfaei. Cyp1b1 gene: implications in glaucoma and cancer. Journal of Cancer, 11(16):4652–4661, 2020. URL: http://dx.doi.org/10.7150/jca.42669, doi:10.7150/jca.42669. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.42669)

[6. (Song2022Cytochrome) Yong-Seok Song, Andrew J. Annalora, Craig B. Marcus, Colin R. Jefcoate, Christine M. Sorenson, and Nader Sheibani. Cytochrome p450 1b1: a key regulator of ocular iron homeostasis and oxidative stress. Cells, 11(19):2930, September 2022. URL: http://dx.doi.org/10.3390/cells11192930, doi:10.3390/cells11192930. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells11192930)

[7. (ChavarriaSoley2008Mutations) Gabriela Chavarria-Soley, Heinrich Sticht, Eleni Aklillu, Magnus Ingelman-Sundberg, Francesca Pasutto, André Reis, and Bernd Rautenstrauss. Mutations in cyp1b1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme. Human Mutation, 29(9):1147–1153, September 2008. URL: http://dx.doi.org/10.1002/humu.20786, doi:10.1002/humu.20786. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20786)

[8. (Lewis1999Molecular) David F.V. Lewis, Brian G. Lake, Stephen G. George, Maurice Dickins, Peter J. Eddershaw, Michael H. Tarbit, Alan P. Beresford, Peter S. Goldfarb, and F.Peter Guengerich. Molecular modelling of cyp1 family enzymes cyp1a1, cyp1a2, cyp1a6 and cyp1b1 based on sequence homology with cyp102. Toxicology, 139(1–2):53–79, November 1999. URL: http://dx.doi.org/10.1016/s0300-483x(99)00098-0, doi:10.1016/s0300-483x(99)00098-0. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0300-483x(99)00098-0)

[9. (Roos2005Cytochrome) Peter H Roos and Hermann M Bolt. Cytochrome p450 interactions in human cancers: new aspects considering cyp1b1. Expert Opinion on Drug Metabolism &amp; Toxicology, 1(2):187–202, August 2005. URL: http://dx.doi.org/10.1517/17425255.1.2.187, doi:10.1517/17425255.1.2.187. This article has 78 citations.](https://doi.org/10.1517/17425255.1.2.187)

[10. (Yablokov2017Thermodynamics) Evgeny Yablokov, Anna Florinskaya, Alexei Medvedev, Gennady Sergeev, Natallia Strushkevich, Alexander Luschik, Tatsiana Shkel, Irina Haidukevich, Andrei Gilep, Sergey Usanov, and Alexis Ivanov. Thermodynamics of interactions between mammalian cytochromes p450 and b5. Archives of Biochemistry and Biophysics, 619:10–15, April 2017. URL: http://dx.doi.org/10.1016/j.abb.2017.02.006, doi:10.1016/j.abb.2017.02.006. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2017.02.006)

[11. (Vasiliou2008Role) Vasilis Vasiliou and Frank J. Gonzalez. Role of cyp1b1 in glaucoma. Annual Review of Pharmacology and Toxicology, 48(1):333–358, February 2008. URL: http://dx.doi.org/10.1146/annurev.pharmtox.48.061807.154729, doi:10.1146/annurev.pharmtox.48.061807.154729. This article has 127 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.pharmtox.48.061807.154729)